tetrandrine has been researched along with Cancer of Colon in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, N; Kuang, H; Li, J; Niu, W; Wang, Q; Wang, Z; Yang, B | 1 |
| Chen, Y; Li, W; Liu, X; Mei, L; Wan, J; Wang, J; Wang, Z; Yu, C | 1 |
| He, BC; Huang, J; Jin, JL; Sun, WJ; Wan, LH; Wang, DX; Wu, K; Wu, QX; Yang, JQ; Yuan, SX; Zhou, M | 1 |
| Chen, QZ; He, BC; He, F; Hu, XL; Huang, M; Li, Y; Liu, RX; Ren, WY; Shao, Y; Sun, WJ; Wu, K; Zeng, YH; Zhou, LY | 1 |
| Hu, J; Hu, WJ; Li, M; Liu, BR; Qian, XP; Sun, J; Yu, LX | 1 |
| Chen, JC; Chen, Y; Lin, TY; Tseng, SH; Wu, JM | 1 |
| Hayward, L; Meng, LH; Pommier, Y; Shao, RG; Takemura, H; Zhang, H | 1 |
7 other study(ies) available for tetrandrine and Cancer of Colon
| Article | Year |
|---|---|
Tetrandrine inhibits colon carcinoma HT-29 cells growth via the Bcl-2/Caspase 3/PARP pathway and G1/S phase.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Caspase 3; Cell Proliferation; Colonic Neoplasms; G1 Phase; HT29 Cells; Humans; Molecular Docking Simulation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; S Phase; Signal Transduction | 2019 |
Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Benzylisoquinolines; Caspase 3; Cell Survival; Chloroquine; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Synergism; HCT116 Cells; HeLa Cells; Humans; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
The role of IGFBP-5 in mediating the anti-proliferation effect of tetrandrine in human colon cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Cell Proliferation; Colonic Neoplasms; Female; Humans; Insulin-Like Growth Factor Binding Protein 5; Male; Mice; Mice, Nude; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
TGF-β1/PTEN/PI3K signaling plays a critical role in the anti-proliferation effect of tetrandrine in human colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; HCT116 Cells; Humans; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Transforming Growth Factor beta1 | 2017 |
[Inhibitory effect of tetrandrine on angiogenesis].
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Endothelial Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neoplasm Transplantation; Neovascularization, Pathologic; Umbilical Veins | 2008 |
Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; In Situ Nick-End Labeling; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Signal Transduction; Time Factors; Tumor Burden | 2010 |
Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Growth Processes; Colonic Neoplasms; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Down-Regulation; G1 Phase; HCT116 Cells; HT29 Cells; Humans; Models, Molecular; Proto-Oncogene Proteins; S Phase; Tumor Suppressor Protein p53 | 2004 |